Phenylethanolamine N-methyltransferase G-148A genetic variant and weight loss in obese women

Obesity Research

Volumn 11, Issue 3, 2003, Pages 415-419

  Peters, Warren R ^a   MacMurry, James P ^b   Walker, Jennifer ^a   Giese Jr , Russell J ^c   Comings, David E ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF WISCONSIN LA CROSSE   (United States)

Author keywords

Epinephrine; Gene transcription; Lifestyle; Thermogenesis

Indexed keywords

ANOREXIGENIC AGENT; CYCLOBUTANE DERIVATIVE; PHENYLETHANOLAMINE N METHYLTRANSFERASE; SIBUTRAMINE;

AGED; ARTICLE; BEHAVIOR THERAPY; BODY CONSTITUTION; CALORIC INTAKE; CASE CONTROL STUDY; DIET; DIETARY FIBER; ESTROGEN THERAPY; EXERCISE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIFESTYLE; MIDDLE AGED; OBESITY; PATIENT EDUCATION; QUESTIONNAIRE; REGRESSION ANALYSIS; TIME; WEIGHT REDUCTION;

AGED; APPETITE DEPRESSANTS; BEHAVIOR THERAPY; BODY CONSTITUTION; CASE-CONTROL STUDIES; CYCLOBUTANES; DIET; DIETARY FIBER; ENERGY INTAKE; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LIFE STYLE; MIDDLE AGED; OBESITY; PATIENT EDUCATION; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; POLYMORPHISM, GENETIC; QUESTIONNAIRES; REGRESSION ANALYSIS; TIME FACTORS; WEIGHT LOSS;

EID: 0037532401     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.56     Document Type: Article

References (13)

1. Couillard C, Mauriege P, Prud'homme D, et al. Plasma leptin response to an epinephrine infusion in lean and obese women. Obes Res. 2002;10:6-13
2. Jelokova J, Rusnak M, Kubovckova L, et al. Stress increases gene expression of phenylethanolamine N-methyltransferase in spleen of rats via pituitary-adrenocortical mechanism. Psychoneroendocrinology. 2002;27:619-33.
3. Reasoner CA. Promising new approaches. Diab Obes Metab. 1999;1(Suppl 1):S41-8.
4. Hansen DL, Toubro S, Stock MJ, MacDonald IA, Astrup A. Thermogenic effects of sibutramine in humans. Am J Clin Nutr. 1998;68:1180-6.
5. Hirsch J, Mackintosh RM, Aronne LJ. The effects of drugs used to treat obesity on the autonomic nervous system. Obes Res. 2000;8:227-33.
6. Hoehe MR, Plaetke R, Otterud B. Genetic Linkage of the human gene for phenylethanolamine N-methyltransferase (PNMT), the adrenaline-synthesizing enzyme, to DNA markers on chromosome 17q21-22. Hum Mol Genet. 1992;1:175-8.
7. Bottner A, Haidan A, Eisenhofer G. Increased body fat mass and suppression of circulating leptin levels in response to hypersecretion of epinephrine in phenylethanolamine N-methyltransferase (PNMT)-overexpressing mice. Endocrinology. 2000;141:4239-46.
8. Wu S, Comings DE. Two single nucleotide polymorphisms in the promotor region of the human phenylethanolamine N-methyltransferase PNMT gene. Psychiatr Genet. 999;9:187-8.
9. Commings DE, MacMurray JP. Molecular heterosis: a review. Mol Genet Metab. 2000;71:19-31.
10. Mann MG, Wu S, Rostamkani M. Phenylethanolamine N-methethyltransferase PNMT gene and early-onset Alzheimer disease. Am J Med Genet. 2001;105:312-6.
11. Emdin M, Gastaldelli A, Muscelli E, et al. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation. 2001;103:513-9.
12. Matsumoto T, Miyawake C, Ue H, Kanda T, Yoshitake Y, Moritani T. Comparison of thermogenic sympathetic response to food intake between obese and non-obese young women. Obes Res. 2001 9:78-85.
13. Levin BE, Dunn-Meynell AA. Sibutramine alters the central mechanisms regulating the defined body weight in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol. 2000;279:R2222-8.